896 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
1 Recruiting Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Condition: Type 2 Diabetes
Interventions: Other: 1: incretin-based therapy;   Other: 2: other antidiabetic
2 Recruiting Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes
Condition: Type-2 Diabetes Mellitus
Interventions: Drug: Oral hypoglycemic agents (pre-specified) [Metformin, Sulfonylurea];   Dietary Supplement: Fenugreek Seed extract
3 Recruiting Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Exenatide;   Drug: Glargine;   Drug: Oral antidiabetic drugs;   Drug: Rapid-acting insulin analogs
4 Unknown  Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
5 Recruiting Adipose Tissue Imaging in Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Radiation: 18F-FDG PET/CT;   Device: euglycemic clamp;   Device: hypoglycemic clamp
6 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Lixisenatide (AVE0010);   Drug: Oral anti-diabetic drugs
7 Not yet recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine (HOE901);   Drug: Oral anti-diabetic drugs
8 Not yet recruiting Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Hypoglycemia
Interventions: Drug: Exenatide;   Drug: Placebo
9 Recruiting Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
Condition: Hypoglycemia
Interventions: Drug: ZP4207;   Drug: GlucaGen
10 Recruiting Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
Conditions: Type 2 Diabetes Mellitus;   Bariatric Surgery;   Biliopancreatic Diversion
Interventions: Procedure: biliopancreatic diversion;   Drug: antidiabetics
11 Recruiting Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes
Conditions: Cystic Fibrosis;   Cystic Fibrosis Related Diabetes
Interventions: Other: Oral Glucose Tolerance Test;   Other: Mixed Meal Tolerance Test;   Other: Hypoglycemic Clamp
12 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Biological: MSC
13 Recruiting Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Condition: Hypoglycemia
Intervention: Procedure: euglycemic and hypoglycemic clamp
14 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
15 Recruiting Oral Antidiabetic Agents in Pregnancy
Condition: Gestational Diabetes
Interventions: Drug: Metformin;   Drug: Glyburide
16 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
17 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
18 Unknown  Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo;   Other: Mixed meal test;   Drug: Liraglutide
19 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Pioglitazone;   Other: Placebo
20 Recruiting Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Ethanol;   Drug: Xeris Glucagon

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years